featured
Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American College of Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial
J Am Coll Cardiol 2020 Oct 06;76(14)1660-1670, BM Everett, JG MacFadyen, T Thuren, P Libby, RJ Glynn, PM RidkerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.